Oncology Nutrition Market Revenue Anticipated To Reach $3.27 Billion By 2030 With 9.4% CAGR

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Expected Market Value Outlook For The Oncology Nutrition Market Through 2030?

The oncology nutrition market has experienced robust expansion in recent years. This market is projected to grow from $2.08 billion in 2025 to $2.28 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.6%. Historically, this growth has been attributed to several factors including increasing awareness about nutrition in cancer care, the growing prevalence of cancer types such as breast, blood, and gastrointestinal cancers, the rising hospital and homecare adoption of enteral and parenteral nutrition, the development of specialized oncology nutrition formulas, and the expansion of specialty clinics for cancer care.

The oncology nutrition market is projected to experience robust expansion in the coming years. By 2030, this market is predicted to reach a value of $3.27 billion, exhibiting a compound annual growth rate (CAGR) of 9.4%. This anticipated growth is driven by several factors, including an increased need for tailored oncology nutrition plans, wider use of technology for nutrition tracking, the expansion of homecare and outpatient nutrition support, a greater emphasis on enhancing patient outcomes through diet, and the spread of oncology nutrition services into developing markets. Key trends during this period are expected to encompass the growing use of digital health platforms for monitoring oncology nutrition, the greater incorporation of AI into individualized cancer diet planning, an expanding application of genomics and precision medicine in dietary interventions, increased automation within hospital and homecare nutrition services, and enhanced IoT-enabled oversight of nutritional provisions and patient adherence.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6745&type=smp

What Market Drivers Are Helping Shape The Oncology Nutrition Market Expansion?

The growing prevalence of cancer is significantly contributing to the future expansion of the oncology nutrition market. Cancer incidence refers to the count of new cancer cases emerging in a specified population over a particular duration. Individuals suffering from cancer require adequate food with sufficient nutrition. As a result, the increasing incidence of cancer raises the demand for oncology nutrition. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, it was projected that by 2050, over 35 million new cancer cases would occur, representing a 77% increase compared to the estimated 20 million cases in 2022. Therefore, the rising incidence of cancer will contribute to the growth of the oncology nutrition market.

What Segment Categories Are Evaluated In The Oncology Nutrition Market Study?

The oncology nutrition market covered in this report is segmented –

1) By Cancer Type: Blood Cancer, Breast Cancer, Stomach And Gastrointestinal Cancers, Liver Cancer, Pancreatic Cancer, Other Cancer Types

2) By Nutrition: Enteral Nutrition, Parenteral Nutrition

3) By End-Users: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Blood Cancer: Leukemia, Lymphoma, Multiple Myeloma

2) By Breast Cancer: Early-Stage Breast Cancer, Advanced Breast Cancer

3) By Stomach And Gastrointestinal Cancers: Gastric Cancer, Colorectal Cancer, Esophageal Cancer

4) By Liver Cancer: Hepatocellular Carcinoma, Cholangiocarcinoma

5) By Pancreatic Cancer: Exocrine Pancreatic Cancer, Endocrine Pancreatic Tumors

6) By Other Cancer Types: Lung Cancer, Prostate Cancer, Ovarian Cancer, Head And Neck Cancers

What Trends Are Influencing The Oncology Nutrition Market Outlook?

Leading companies within the oncology companion diagnostics market are focusing their efforts on developing advanced high-throughput sequencing technologies, such as the implementation of c-MET companion diagnostic assays for therapeutic guidance in advanced non-small cell lung cancer, aiming to enhance precision oncology and individualized treatment selection. The application of c-MET companion diagnostic assays for guiding therapy in advanced non-small cell lung cancer involves deploying a targeted diagnostic test designed to detect c-MET gene alterations in patients with advanced non-small cell lung cancer (NSCLC), enabling clinicians to choose appropriate therapies, optimize treatment effectiveness, and support precision medicine approaches. For instance, in May 2025, NeoGenomics, Inc., a US-based oncology testing company, launched its c-MET CDx Assay to assist in treatment decisions for patients with advanced Non-Small Cell Lung Cancer (NSCLC). This c-MET CDx Assay is a companion diagnostic test specifically engineered to detect c-MET protein overexpression in tumor tissue, delivering rapid and accurate results to identify individuals who may benefit from MET-targeted therapies. The assay is distinguished by its high sensitivity and specificity, prompt turnaround times, standardized testing procedures, and compatibility with routine clinical workflows, making it highly suitable for precision oncology and personalized treatment planning.

Which Companies Form The Competitive Landscape Of The Oncology Nutrition Market?

Major companies operating in the oncology nutrition market are B. Braun Melsungen AG, Abbott Laboratories, Abbott Nutrition, Nestle S.A., Nutricia, Baxter International Inc., Fresenius Kabi AG, Fresenius Kabi USA LLC, Global Health Products Inc., Cambrooke Therapeutics Inc., Kate Farms Inc., Real Food Blends LLC, Medtrition Inc., Nutra Balance Products, Nutritional Medicinals LLC, Primus Pharmaceuticals Inc., Solace Nutrition, Unimed Pharma LLC, Vitaflo USA LLC, Danone S.A., Ajinomoto Co Ltd, Otsuka Pharmaceutical Co Ltd, Grifols S.A., Victus Inc, Esperer Nutrition

Access The Complete Oncology Nutrition Market Report:

https://www.thebusinessresearchcompany.com/report/oncology-nutrition-global-market-report

Which Region Contributes The Most To The Oncology Nutrition Market?

North America was the largest region in the oncology nutrition market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oncology nutrition market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Oncology Nutrition Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=6745&type=smp

Browse Through More Reports Similar to the Global Oncology Nutrition Market 2026, By The Business Research Company

Oncology Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/oncology-devices-global-market-report

Oncology Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/oncology-drugs-market

Oncology Ablation Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/oncology-ablation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795